Licofelone: the answer to unmet needs in osteoarthritis therapy?

Abstract

Licofelone, a competitive inhibitor of cyclooxygenases 1 and 2 and 5-lipoxygenase enzyme, is under clinical evaluation for its effectiveness in the treatment of osteoarthritis (OA). Licofelone decreases the production of both prostaglandins and leukotrienes and has been shown to possess a combination of analgesic or anti-inflammatory effects with a… (More)

Topics

Cite this paper

@article{Kulkarni2008LicofeloneTA, title={Licofelone: the answer to unmet needs in osteoarthritis therapy?}, author={Shrinivas Kulkarni and Vijay P Singh}, journal={Current rheumatology reports}, year={2008}, volume={10 1}, pages={43-8} }